MedTrace Logo

Safety of Stem Cells Intrabronchial Instillation for Silicosis

NCT01239862 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2015-05-27

No results posted yet for this study

Summary

The aim of this study was to analyze the safety, pulmonary function, and quality of life data of patients with silicosis treated with intrabronchial instillation of bone marrow derived mononuclear cells (BMDMC, 2x107) through bronchoscopy.

Conditions

  • Chronic and Accelerated Silicosis

Interventions

OTHER

Autologous cell transplantation

Intrabronchial Instillation Of Bone Marrow Derived Mononuclear Cells

Sponsors & Collaborators

  • Ministry of Science and Technology, Brazil

    collaborator OTHER

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • National Research Council, Brazil

    collaborator OTHER

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-05-31
Completion
2013-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01239862 on ClinicalTrials.gov